Life Sciences 1982-11-08

HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro.

D Ruppert, K U Weithmann

Index: Life Sci. 31 , 2037, (1982)

Full Text: HTML

Abstract

The new pyrimido-isoquinoline compound HL 725 is an extremely potent inhibitor of the aggregation of human platelets induced in vitro by ADP, collagen, thrombin and epinephrine. The aggregation induced by 0,5 mM arachidonic acid is inhibited about 50% with 50 pM HL 725. Thus the potency of HL 725 is higher than that of prostacyclin, the most active natural inhibitor of aggregation. We hypothesize that HL 725 inhibits the enzymatic degradation of cyclic adenosine 3', 5'-monophosphate (cAMP) in the platelets. In accordance with this proposal is the strong inhibitory action on cAMP phosphodiesterase extracted from human platelets. About 250 pM HL 725 inhibited 50% of the activity of this enzyme at a substrate concentration of 0.5 microM. A marked elevation of cAMP levels in human platelets could be demonstrated after incubation in vitro with 100 nM HL 725.


Related Compounds

Related Articles:

H4 histamine receptors inhibit steroidogenesis and proliferation in Leydig cells.

2014-12-01

[J. Endocrinol. 223(3) , 241-53, (2014)]

Sinensetin enhances adipogenesis and lipolysis by increasing cyclic adenosine monophosphate levels in 3T3-L1 adipocytes.

2015-01-01

[Biol. Pharm. Bull. 38(4) , 552-8, (2015)]

Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis.

2014-05-14

[J. Neurosci. 34(20) , 6910-23, (2014)]

Prostacyclin receptor expression on platelets of humans with type 2 diabetes is inversely correlated with hemoglobin A1c levels.

2015-01-01

[Prostaglandins Other Lipid Mediat. 116-117 , 131-5, (2015)]

The regions within the N-terminus critical for human glucagon like peptide-1 receptor (hGLP-1R) cell surface expression.

2014-01-01

[Sci. Rep. 4 , 7410, (2014)]

More Articles...